Historical Valuation
Outset Medical Inc (OM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.56 is considered Undervalued compared with the five-year average of -8.24. The fair price of Outset Medical Inc (OM) is between 17.66 to 117.20 according to relative valuation methord. Compared to the current price of 4.67 USD , Outset Medical Inc is Undervalued By 73.56%.
Relative Value
Fair Zone
17.66-117.20
Current Price：4.67
73.56%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Outset Medical Inc (OM) has a current Price-to-Book (P/B) ratio of 0.48. Compared to its 3-year average P/B ratio of 2.22 , the current P/B ratio is approximately -78.59% higher. Relative to its 5-year average P/B ratio of 3.30, the current P/B ratio is about -85.61% higher. Outset Medical Inc (OM) has a Forward Free Cash Flow (FCF) yield of approximately -80.27%. Compared to its 3-year average FCF yield of -105.13%, the current FCF yield is approximately -23.65% lower. Relative to its 5-year average FCF yield of -66.42% , the current FCF yield is about 20.85% lower.
P/B
Median3y
2.22
Median5y
3.30
FCF Yield
Median3y
-105.13
Median5y
-66.42
Competitors Valuation Multiple
AI Analysis for OM
The average P/S ratio for OM competitors is 8.53, providing a benchmark for relative valuation. Outset Medical Inc Corp (OM.O) exhibits a P/S ratio of 0.56, which is -93.38% above the industry average. Given its robust revenue growth of 2.67%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for OM
1Y
3Y
5Y
Market capitalization of OM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of OM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is OM currently overvalued or undervalued?
Outset Medical Inc (OM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.56 is considered Undervalued compared with the five-year average of -8.24. The fair price of Outset Medical Inc (OM) is between 17.66 to 117.20 according to relative valuation methord. Compared to the current price of 4.67 USD , Outset Medical Inc is Undervalued By 73.56% .
What is Outset Medical Inc (OM) fair value?
OM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Outset Medical Inc (OM) is between 17.66 to 117.20 according to relative valuation methord.
How does OM's valuation metrics compare to the industry average?
The average P/S ratio for OM's competitors is 8.53, providing a benchmark for relative valuation. Outset Medical Inc Corp (OM) exhibits a P/S ratio of 0.56, which is -93.38% above the industry average. Given its robust revenue growth of 2.67%, this premium appears unsustainable.
What is the current P/B ratio for Outset Medical Inc (OM) as of Jan 09 2026?
As of Jan 09 2026, Outset Medical Inc (OM) has a P/B ratio of 0.48. This indicates that the market values OM at 0.48 times its book value.
What is the current FCF Yield for Outset Medical Inc (OM) as of Jan 09 2026?
As of Jan 09 2026, Outset Medical Inc (OM) has a FCF Yield of -80.27%. This means that for every dollar of Outset Medical Inc’s market capitalization, the company generates -80.27 cents in free cash flow.
What is the current Forward P/E ratio for Outset Medical Inc (OM) as of Jan 09 2026?
As of Jan 09 2026, Outset Medical Inc (OM) has a Forward P/E ratio of -1.28. This means the market is willing to pay $-1.28 for every dollar of Outset Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Outset Medical Inc (OM) as of Jan 09 2026?
As of Jan 09 2026, Outset Medical Inc (OM) has a Forward P/S ratio of 0.56. This means the market is valuing OM at $0.56 for every dollar of expected revenue over the next 12 months.